The EANM guideline for radiosynoviorthesis

Yazar
Panagiotidis, E.
Van den Wyngaert, T.
Antunovic, L.
Gnanasegaran, G.
Kuwert, T.
Kampen, W. U.
Boddenberg-Paetzold, B.
Fischer, M.
Gabriel, M.
Klett, R.
Konijnenberg, M.
Kresnik, E.
Lellouche, H.
Paycha, F.
Terslev, L.
Turkmen, C.
van der Zant, F.
Üst veri
Tüm öğe kaydını göster
Özet
Purpose Radiosynoviorthesis (RSO) using the intraarticular application of beta-particle emitting radiocolloids has for decades been used for the local treatment of inflammatory joint diseases. The injected radiopharmaceuticals are phagocytized by the superficial macrophages of the synovial membrane, resulting in sclerosis and fibrosis of the formerly inflamed tissue, finally leading to reduced joint effusion and alleviation of joint pain.
Bağlantı
http://hdl.handle.net/20.500.12627/169174
https://doi.org/10.1007/s00259-021-05541-7
Koleksiyonlar